Mild cervical dysplasia
ICD-10 N87.0 is a billable code used to indicate a diagnosis of mild cervical dysplasia.
Mild cervical dysplasia, classified under ICD-10 code N87.0, refers to the presence of abnormal cells on the surface of the cervix that are not cancerous but indicate a potential for future changes. This condition is often detected through routine Pap smears, which may reveal atypical squamous cells. Mild dysplasia is typically categorized as CIN 1 (cervical intraepithelial neoplasia grade 1), indicating that the abnormal cells are confined to the lower third of the epithelial layer of the cervix. While mild dysplasia may resolve spontaneously without treatment, it necessitates careful monitoring due to the risk of progression to more severe dysplasia or cervical cancer. Risk factors include human papillomavirus (HPV) infection, smoking, and a weakened immune system. Management may involve repeat Pap testing, HPV testing, or colposcopy for further evaluation. Education on preventive measures, such as HPV vaccination and regular screenings, is crucial for patients diagnosed with mild cervical dysplasia.
Detailed documentation of Pap smear results, HPV status, and follow-up plans.
Routine screening, abnormal Pap results, and management of dysplasia.
Ensure accurate coding of severity and follow-up procedures.
Clear reporting of biopsy findings and histological grading.
Biopsy interpretation and reporting of cervical tissue samples.
Pathology reports must correlate with clinical findings for accurate coding.
Used during routine screening for cervical dysplasia.
Document the date of the Pap smear and results.
Gynecologists must ensure accurate coding based on findings.
Performed when mild dysplasia is detected to evaluate further.
Document indications for colposcopy and findings.
Pathologists must correlate findings with clinical history.
Mild cervical dysplasia indicates abnormal cell changes that may resolve on their own but require monitoring due to the potential risk of progression to more severe dysplasia or cervical cancer.
Follow-up Pap smears are typically recommended every 6 to 12 months, depending on the patient's history and risk factors.
